GS0401: Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for others, custom manufacture and assembly services, custom assembly for others of electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic components, semi-conductor components and circuits for medical apparatus and equipment
DM0000: The mark consists of the stacked wording "XPERT ALLIANCE" in blue. To the right of the term "XPERT" appears the wording "RENTSCHLER" in orange above the wording "& VETTER" in orange. All the aforesaid appears above the wording "SUBSTANCE PRODUCT PATIENT" in black with these terms separated by orange triangles.
GS0391: Bottling services and storage of goods in the nature of liquid and solid substances, especially, pharmaceuticals, medicines and solutions, for others
PM0001: EXPERT ALLIANCE RENTSCHLER AND VETTER SUBSTANCE PRODUCT PATIENT
CC0000: The color(s) black, blue, and orange is/are claimed as a feature of the mark.
GS0441: Medical services; medical assistance; animal healthcare services, namely, animal breeding, animal grooming, medical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical products, namely, providing medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products
D10000: "EXPERT ALLIANCE"
GS0421: Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research services, namely, chemical, biochemical, biological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry services, namely, chemistry consultation, research in the fields of chemistry; biochemical services, namely, biochemistry consultation, research in the fields of biochemistry; services of medical, bacteriological and chemical laboratories, namely, laboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceutical, veterinary and diagnostic products and substances and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means, in the nature of research in the field of manufacturing machinery for pharmaceutical, veterinary and diagnostic products and substances, design and development of computer hardware for the pharmaceutical, veterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacy, namely, consulting services in the field of pharmaceutical research and development, technical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnostics, namely, consulting services in the field of pharmaceutical research and development, consulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injections, injectors and packaging for the aforesaid goods for others; product quality and product safety testing, namely, chemical testing, physical testing and process engineering testing, in particular laboratory testing; pharmacological and microbiological development, research and analysis for others; conducting clinical tests, namely, scientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy
Case File Event Statements
3/26/2024 - 2 months ago
25 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
3/26/2024 - 2 months ago
24 - REGISTERED-PRINCIPAL REGISTERType:R.PR
1/9/2024 - 4 months ago
23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
1/9/2024 - 4 months ago
22 - PUBLISHED FOR OPPOSITIONType:PUBO
1/8/2024 - 4 months ago
21 - NOTIFICATION PROCESSED BY IBType:GPNX
12/20/2023 - 5 months ago
20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
12/20/2023 - 5 months ago
19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
12/20/2023 - 5 months ago
18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
12/5/2023 - 5 months ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
12/5/2023 - 5 months ago
16 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
12/5/2023 - 5 months ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
12/5/2023 - 5 months ago
14 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
12/5/2023 - 5 months ago
13 - EXAMINERS AMENDMENT -WRITTENType:CNEA
11/9/2023 - 6 months ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
11/9/2023 - 6 months ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
11/9/2023 - 6 months ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
6/7/2023 - 11 months ago
9 - REFUSAL PROCESSED BY IBType:RFNP
5/12/2023 - a year ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
5/11/2023 - a year ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
3/22/2023 - a year ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
3/21/2023 - a year ago
5 - NON-FINAL ACTION WRITTENType:CNRT
3/11/2023 - a year ago
4 - ASSIGNED TO EXAMINERType:DOCK
2/14/2023 - a year ago
3 - APPLICATION FILING RECEIPT MAILEDType:MAFR
2/10/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
2/9/2023 - a year ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
Trademark
79362259
